Form 8-K - Current report:
SEC Accession No. 0001140361-25-011158
Filing Date
2025-03-31
Accepted
2025-03-31 07:00:22
Documents
15
Period of Report
2025-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20046464_8k.htm   iXBRL 8-K 34108
2 EXHIBIT 10.1 ef20046464_ex10-1.htm EX-10.1 109934
6 image00001.jpg GRAPHIC 2571
  Complete submission text file 0001140361-25-011158.txt   308823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ngvt-20250330.xsd EX-101.SCH 3982
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ngvt-20250330_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ngvt-20250330_pre.xml EX-101.PRE 16044
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20046464_8k_htm.xml XML 4073
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 25788790
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)